AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (1.6 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Publishing Language: Chinese | Open Access

Association of HLA genotypes with the risk of hematological malignancies and immune checkpoint-related proteins

Qian Wang1, Shuang Liang1, Qingyin Bu1, Longhu Sun1, Junru Zhu1, Miaomiao Zhu1, Juncheng Dai1,2,3 ( )
Department of Epidemiology, Center for Global Health, Nanjing Medical University, Nanjing 211166
Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Medicine and China International Cooperation Center for Environment and Human Health, Nanjing Medical University, Nanjing 211166
Genomic Science and Precision Medicine Institute, Gusu School, Nanjing Medical University, Suzhou 215000, China
Show Author Information

Abstract

Objective

To systematically evaluate the association between human leukocyte antigen (HLA) genotypes and the risk of hematological malignancies (HM) and explore the correlation between HM-related HLA and protein levels.

Methods

Based on data from 438464 participants in the prospective cohort UK Biobank (UKB), the Cox proportional hazards regression model was used to assess the associations between HLA genotypes and the risk of incident HM, and the multiple linear regression model was used to evaluate the correlation between HLA and plasma protein levels. All models were adjusted for age, sex, genotyping batch, and the top five gene principal components (PCs).

Results

Ten HLA genotypes were identified as significantly associated with the risk of HM. The development of lymphoid malignancies (Hodgkin lymphoma, non-Hodgkin lymphoma, and lymphocytic leukemia) was jointly influenced by both HLA-Ⅰ and HLA-Ⅱ loci. Specifically, B*08: 01, C*07: 01, DQA1*05: 01, DQB1*02: 01, DRB1*03: 01, and DRB3*01: 01 consistently increased the incidence risk of lymphoid malignancies. In contrast, the risk of multiple myeloma was exclusively associated with HLA-Ⅰ locus B*07: 02 (HR=1.30, 95% CI: 1.14-1.47, Padj=0.009) and C*07: 02 (HR=1.30, 95% CI: 1.15-1.47, Padj=0.009). Enrichment analysis demonstrated that HLA-related proteins were significantly enriched in cell adhesion molecule interactions, as well as core immune signaling pathways including PI3K-Akt, MAPK, and NF-κB. Furthermore, HM-susceptible HLA genotypes significantly influenced the expression levels of four immune checkpoint-related protein families: killer cell immunoglobulin-like receptors, leukocyte immunoglobulin-like receptors, programmed cell death proteins, and TIGIT.

Conclusion

The HLA genotype is closely related to the susceptibility to HM, and the key biomarkers for assessing high-risk populations for HM may potentially be mediated through the regulation of immune checkpoint proteins and related signaling pathways.

CLC number: R733 Document code: A Article ID: 1007-4368(2026)11-1610-09

References

【1】
【1】
 
 
Journal of Nanjing Medical University (Natural Sciences)
Pages 1610-1618

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Wang Q, Liang S, Bu Q, et al. Association of HLA genotypes with the risk of hematological malignancies and immune checkpoint-related proteins. Journal of Nanjing Medical University (Natural Sciences), 2026, 46(11): 1610-1618. https://doi.org/10.7655/NYDXBNSN260518

3

Views

0

Downloads

0

Crossref

Received: 23 April 2026
Revised: 05 June 2026
Accepted: 16 July 2026
Published: 15 November 2026
© 2026 Editorial Board of Journal of Nanjing Medical University(Natural Sciences)

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).